UBS Group’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History
Bought
Maintained
Sold
Other funds holding CURE
GS
SS
TCM
SF
OBWG
PWPS
TRCT
UBS Group's CURE Position: Q1 2026 in Review
UBS Group sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q1 2026, closing a stake of 418 shares — an estimated $46.6K sold.
UBS Group first reported a position in CURE in Q1 2015 and held it in 31 quarters. The position peaked at $549K in Q1 2025. 15 funds tracked by Wall St. Rank hold CURE as of Q1 2026.
- UBS Group reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q1 2026 after selling out during the quarter.
- UBS Group sold 418 Direxion Daily Healthcare Bull 3X ETF shares in Q1 2026, an estimated $46.6K.
- UBS Group first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q1 2015 and held it in 31 quarters.
- UBS Group's Direxion Daily Healthcare Bull 3X ETF position peaked at $549K in Q1 2025.
- 15 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.